Most importantly control what you can......
which would be to schedule testing for software and hardware, and continue to develop IP.
Both of which will continue to build value and create pressure on those that wish to compete in the RAS market.
The further along we get with ENOS and our IP, the shorter the distance to some form of action to acquire our company.
Someone keeps harping on the sp, and the value of a few hundred million. I call BS. SERIOUSLY....
What's the value of ISRG's SP? Sure, it works. But it's not for sale. Vicarious is supposedly merging with D8, once those lawsuits get cleared up. Wonder how long that takes, and delays it creates?
My point is our value is NOT based on our current sp. It's what ENOS does near-term and what our IP can do for the next 20-30 years. Over the course of the next 2-3 decades, I would speculate that miniaturization will have an amazing effect. But you still have to own the base patents from which to miniaturize.
Our value is tied to ENOS 1.xx near term. However our BO value should include - by extension ENOS 2.x, 3.x and the future value of the additional applicability of our IP. While this is speculative, we have a clearly defined road map as it has played out for ISRG. We just have a better mouse trap.
I think there will be Wall Street participation in the sp run up, b/c there's no stopping it. It's also highly speculative that ISRG would take a swing at TMDI. That's not out of the realm of possibility. I also think MDT will do their legal best to keep the sp from running away, which we saw with Mazor. Also, I can foresee wild speculation in the open market as to the final BO sp b/c we are currently publicly traded. I hope. For me, it's only a question of when - not if. IMO.
Previously, I've made my case for $38.50/share. I'm revising it upward to between $42.00-$48.00 per share. Using approximately 150M outstanding shares at the time of BO announcement. I'm increasing the number of total outstanding shares for this estimate, b/c if my estimate is incorrect (if the actual count is lower at the time of BO) - it will be to our benefit. But (IMO) 1-2B$ is just silly talk and contrary to the defensible value of 20 year IP, the time value of buying IP instead of organic R&D development, Mazor, eENT, and the individual value of ISRG SP.
Bring on the arguments, but PLEASE bring the supporting substantive details with it. I haven't heard any good, or reasonable supporting arguments yet for a lesser sp.
Good luck to all. Regards,BK.
